These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9482400)

  • 1. Food and Drug Administration regulation of blood bank software: the new regulatory landscape for blood establishments and their vendors.
    Weeda DF; O'Flaherty NF
    Transfusion; 1998 Jan; 38(1):86-9. PubMed ID: 9482400
    [No Abstract]   [Full Text] [Related]  

  • 2. The evolution of the current blood banking regulatory climate.
    Solomon JM
    Transfusion; 1994 Mar; 34(3):272-7. PubMed ID: 8146905
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA & clinical software vendors: a line in the sand?
    Schneider P
    Healthc Inform; 1996 Jun; 13(6):100-2, 104, 106. PubMed ID: 10161397
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter to manufacturers of blood establishment computer software products--FDA. Notice.
    Fed Regist; 1994 Aug; 59(168):44991-2. PubMed ID: 10136917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impending FDA regulations of healthcare software. First stop: blood banking. Interview by Bill W. Childs.
    Marrazzo J
    US Healthc; 1988 Nov; 5(11):17-8. PubMed ID: 10291018
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-referencing of ISO-9000 and regulatory quality systems at blood centers.
    Healy-Collier K
    Top Health Inf Manage; 1998 May; 18(4):32-8. PubMed ID: 10179274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whither the blood products advisory committee?
    Sayers MH
    Transfusion; 1996 Oct; 36(10):932-4. PubMed ID: 8863783
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA accuses Red Cross of unsafe practices. Inspections at embattled blood bank turn up 'serious' violations.
    Becker C
    Mod Healthc; 2001 Dec; 31(51):10. PubMed ID: 11820197
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical device software regulation: an industry perspective.
    Simons D
    Food Drug Law J; 1997; 52(2):189-92. PubMed ID: 10557558
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood investigation.
    AIDS Policy Law; 1996 May; 11(9):12. PubMed ID: 11363471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating blood manufacturing software: report of a conference.
    Macpherson J; Kochman S; McCullough J
    Transfusion; 2009 Nov; 49(11):2490-4. PubMed ID: 19903297
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient safety or profit: what incentives are blood shield laws and FDA regulations creating for the tissue banking industry?
    Williams JL
    Indiana Health Law Rev; 2005; 2(1):295-328. PubMed ID: 17111505
    [No Abstract]   [Full Text] [Related]  

  • 13. Progress in blood supply safety.
    Revelle M
    FDA Consum; 1995 Apr; 29(3):21-4. PubMed ID: 10141840
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood & politics.
    Titus K
    CAP Today; 1996 Mar; 10(3):20, 22-4. PubMed ID: 10160264
    [No Abstract]   [Full Text] [Related]  

  • 15. Extended platelet storage makes a welcome difference.
    Townsend L
    MLO Med Lab Obs; 2007 Jun; 39(6):40-1. PubMed ID: 17691706
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA's proposed regulatory approach to regulation of hematopoietic stem/progenitor cell products.
    Harvath L
    Cytotherapy; 1999; 1(4):358-9. PubMed ID: 20440912
    [No Abstract]   [Full Text] [Related]  

  • 17. AIDS and the blood supply: an analysis of law, regulation, and public policy.
    Salbu SR
    Wash Univ Law Q; 1996; 74(4):913-80. PubMed ID: 16273697
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood bank held to reasonably prudent standard of care, not industry standard.
    J Health Hosp Law; 1991 Oct; 24(10):325-6. PubMed ID: 10183534
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA regulation of biomedical software.
    Gamerman GE
    Proc Annu Symp Comput Appl Med Care; 1992; ():745-9. PubMed ID: 1482971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment: dilemmas of dementia.
    Dodd RY
    J Clin Ethics; 2001; 12(2):141-2. PubMed ID: 11642065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.